Position in BMY
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$404,777,976
+$79,441,080 QoQ
Shares Held
6,673,998
+10.7% QoQ
Ownership
0.327%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 99.29998480670807.ToString("F0")%
Shared 0.7000151932919368.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Amundi holds $19,301,385,364 across 13 Drug Manufacturers - General names. BMY ranks #9 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,055,025 | $4,649,460,337 | |
| 2 | JNJ |
Johnson & Johnson
|
13,406,820 | $3,277,163,076 | |
| 3 | AZN |
Astrazeneca PLC
|
15,386,149 | $3,034,456,300 | |
| 4 | ABBV |
AbbVie Inc.
|
10,698,095 | $2,326,728,674 | |
| 5 | MRK |
Merck & Co., Inc.
|
13,764,954 | $1,655,786,310 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
10,539,111 | $1,468,835,897 | |
| 7 | AMGN |
Amgen Inc
|
3,377,306 | $1,188,305,111 | |
| 8 | PFE |
Pfizer Inc
|
40,825,470 | $1,146,379,191 |
All Filings in BMY
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $404,777,976 | 6,673,998 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $325,336,896 | 6,031,459 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $269,446,428 | 5,974,422 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $267,562,631 | 5,780,139 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $321,227,245 | 5,266,884 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $290,698,482 | 5,139,648 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $403,300,201 | 7,794,747 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $347,669,841 | 8,371,535 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $318,224,991 | 5,868,062 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $256,134,738 | 4,991,907 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $352,692,296 | 6,076,711 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $394,587,543 | 6,170,251 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $538,323,064 | 7,766,889 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $608,075,701 | 8,451,365 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $517,417,467 | 7,278,344 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $412,978,874 | 5,363,362 | Shares | Defined | 2022-09-02 | |
| 2022-03-31 | $304,368,874 | 4,167,724 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $213,511,517 | 3,424,403 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $316,676,298 | 5,351,974 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $354,356,804 | 5,303,155 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||